相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer-secreted miRNAs regulate amino-acid-induced mTORC1 signaling and fibroblast protein synthesis
Miranda Y. Fong et al.
EMBO REPORTS (2021)
Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer
Xiaohan Dong et al.
THORACIC CANCER (2021)
Cisplatin-mediated down-regulation of miR-145 contributes to up-regulation of PD-L1 via the c-Myc transcription factor in cisplatin-resistant ovarian carcinoma cells
Q. Sheng et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer
Qianqian Ren et al.
CANCER CELL INTERNATIONAL (2020)
How microRNAs affect the PD-L1 and its synthetic pathway in cancer
Gholamreza Rezaei Danbaran et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
Eleni Anastasiadou et al.
LEUKEMIA (2019)
FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1
Lola Fashoyin-Aje et al.
ONCOLOGIST (2019)
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
Keisuke Kataoka et al.
LEUKEMIA (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
The Diverse Oncogenic and Tumor Suppressor Roles of microRNA-105 in Cancer
Jie Li et al.
FRONTIERS IN ONCOLOGY (2019)
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Andrew A. Davis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
miR-146a Controls Immune Response in the Melanoma Microenvironment
Justin Mastroianni et al.
CANCER RESEARCH (2019)
Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer
Yanhua Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Epigenetic Coactivation of MAGEA6 and CT-GABRA3 Defines Orientation of a Segmental Duplication in the Human X Chromosome
Jean S. Fain et al.
CYTOGENETIC AND GENOME RESEARCH (2019)
The role of pembrolizumab in the treatment of PD-L1 expressing gastric and gastroesophageal junction adenocarcinoma
Gagandeep Brar et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy
Liisa Chang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells
Wei Yan et al.
NATURE CELL BIOLOGY (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer
Kousaku Mimura et al.
CANCER SCIENCE (2018)
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma
Aniruddha Chatterjee et al.
ISCIENCE (2018)
The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma
Raphaela Schwentner et al.
ONCOTARGET (2017)
Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma
Min-Kyung Yeo et al.
HUMAN PATHOLOGY (2017)
MicroRNA-155 induction via TNF- and IFN- suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells
Daniel Yee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
MicroRNA-105 is involved in TNF-α-related tumor microenvironment enhanced colorectal cancer progression
Zetao Shen et al.
CELL DEATH & DISEASE (2017)
MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma
Yaxin Wang et al.
ONCOTARGET (2017)
IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma
Ji Wook Moon et al.
SCIENTIFIC REPORTS (2017)
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
Hao-Yi Li et al.
BREAST CANCER RESEARCH (2017)
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Keisuke Kataoka et al.
NATURE (2016)
Distribution of miRNA expression across human tissues
Nicole Ludwig et al.
NUCLEIC ACIDS RESEARCH (2016)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival
Dong Kang et al.
PLOS PATHOGENS (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis
Weiying Zhou et al.
CANCER CELL (2014)
A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors
Axelle Loriot et al.
EPIGENETICS (2014)
Widespread context dependency of microRNA-mediated regulation
Florian Erhard et al.
GENOME RESEARCH (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data
Jun-Hao Li et al.
NUCLEIC ACIDS RESEARCH (2014)
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen et al.
NATURE COMMUNICATIONS (2014)
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
Huili Li et al.
ONCOTARGET (2014)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
Maria D. Paraskevopoulou et al.
NUCLEIC ACIDS RESEARCH (2013)
A frequent somatic mutation in CD274 3'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding
Weipeng Wang et al.
HUMAN MUTATION (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
Rebecca L. Skalsky et al.
PLOS PATHOGENS (2012)
Viral MicroRNA Targetome of KSHV-Infected Primary Effusion Lymphoma Cell Lines
Eva Gottwein et al.
CELL HOST & MICROBE (2011)
Modulation of TLR2 Protein Expression by miR-105 in Human Oral Keratinocytes
Manjunatha R. Benakanakere et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
分享论文
